Reckitt Benckiser Group plc (FRA:3RBB)

Market Cap	47.25B +15.7%
Revenue (ttm)	16.31B -3.3%
Net Income	1.45B -22.1%
EPS	2.10 -19.0%
Shares Out	n/a
PE Ratio	32.61
Forward PE	17.25
Dividend	0.46 (3.32%)
Ex-Dividend Date	Aug 8, 2025

Volume	n/a
Average Volume	n/a
Open	13.70
Previous Close	13.70
Day's Range	13.70 - 13.70
52-Week Range	10.60 - 14.10
Beta	n/a
RSI	50.76
Earnings Date	Mar 5, 2026

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products in the United Kingdom and internationally. The company offers germ protection under Dettol name; intimate wellness under Durex and KY brand names; over the counter under the Biofreeze, Gaviscon, Mucinex, Nurofen, and Strepsils names. It also provides personal care products under Clearasil and Veet brand names; vitamins, minerals, and supplements under Airborne, Movefree, and neuriva names; and disinfectant products under the Finish, Harpic, and Lysol bran...

• Industry: Soap, Detergents, And Cleaning Preparations; Perfumes, Cosmetics, and Other Toilet Preparations
• Founded: 1819
• Employees: 37,900
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 3RBB

Financial Performance

In 2024, Reckitt Benckiser Group's revenue was 14.17 billion, a decrease of -3.00% compared to the previous year's 14.61 billion. Earnings were 1.43 billion, a decrease of -13.21%.

Financial numbers in GBP